ResMed, Inc. Stock Deutsche Boerse AG
Stocks
RME
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Tradegate
13:37:17 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 206.50 EUR | +1.77% |
|
+4.94% | +0.44% |
| 08-31 | KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating | MT |
| 08-19 | Rothschild & Co Redburn Initiates ResMed at Neutral With $230 Price Target | MT |
| Market Cap | 34.63B 29.82B 28B 25.56B 48.02B 3,295B 48.36B 332B 129B 1,671B 130B 127B 5,533B | P/E 2027 * |
20.8x | P/E 2028 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 33.69B 29.01B 27.23B 24.86B 46.7B 3,205B 47.04B 323B 126B 1,625B 126B 124B 5,382B | EV / Sales 2027 * |
5.79x | EV / Sales 2028 * | 5.32x |
| Free-Float |
75.13% | Yield 2027 * |
1.11% | Yield 2028 * | 1.22% |
Last Transcript : ResMed, Inc.
| 1 day | +1.77% | ||
| 1 week | +4.94% | ||
| Current month | +15.02% | ||
| 1 month | +15.02% | ||
| 3 months | +27.40% | ||
| 6 months | -5.98% | ||
| Current year | +0.44% |
| 1 week | 197.1 |  | 206 |
| 1 month | 171.6 | | 206 |
| Current year | 155.7 | | 236.3 |
| 1 year | 155.7 | | 246.5 |
| 3 years | 126.4 | | 250.2 |
| 5 years | 126.4 | | 255.5 |
| 10 years | 50.46 | | 255.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
| Chief Tech/Sci/R&D Officer | - | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | +4.94% | - | - | 34.63B | |
| -0.82% | -1.85% | +25.24% | +10.77% | 228B | |
| -1.16% | -0.72% | +3.76% | -19.41% | 150B | |
| +1.14% | +0.88% | -19.66% | +20.53% | 133B | |
| +3.12% | -1.45% | -54.22% | -10.46% | 70B | |
| +0.60% | +0.28% | +11.57% | +18.67% | 52.31B | |
| +0.42% | -2.72% | -17.63% | -15.05% | 50.59B | |
| -0.18% | +0.08% | +22.20% | +26.84% | 43.3B | |
| -0.01% | +0.94% | +37.39% | +47.66% | 40.74B | |
| -0.10% | +3.29% | -12.54% | +50.45% | 34.63B | |
| Average | +0.48% | -0.75% | -0.43% | +14.44% | 89.22B | |
| Weighted average by Cap. | +0.13% | -1.02% | +2.09% | +8.23% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.82B 5.01B 4.7B 4.29B 8.07B 554B 8.12B 55.74B 21.69B 281B 21.85B 21.37B 929B | 6.2B 5.34B 5.01B 4.57B 8.59B 590B 8.65B 59.38B 23.1B 299B 23.27B 22.77B 990B |
| Net income | 1.63B 1.4B 1.32B 1.2B 2.26B 155B 2.27B 15.6B 6.07B 78.57B 6.11B 5.98B 260B | 1.78B 1.53B 1.44B 1.32B 2.47B 170B 2.49B 17.07B 6.64B 85.99B 6.69B 6.55B 285B |
| Net Debt | -947M -816M -766M -699M -1.31B -90.13B -1.32B -9.07B -3.53B -45.7B -3.56B -3.48B -151B | -1.69B -1.45B -1.36B -1.24B -2.34B -160B -2.35B -16.16B -6.29B -81.37B -6.33B -6.19B -269B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | €206.00 | +1.53% | 0 |
| 31/08/26 | €202.90 | -0.05% | 0 |
| 28/08/26 | €203.00 | +1.81% | 0 |
| 27/08/26 | €199.40 | +0.15% | 0 |
| 26/08/26 | €199.10 | +1.01% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- RME Stock
Select your edition
All financial news and data tailored to specific country editions
